Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHA:603168)
China · Delayed Price · Currency is CNY 5.89
-0.11 (-1.83%)
At close: Sep 10, 2026
SHA:603168 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 55.78 | 112.18 | 82.79 | 355.67 | 525.06 | 138.52 |
Trading Asset Securities | 147.86 | 112.22 | 106.86 | 13.53 | 29.27 | 105.03 |
Cash & Short-Term Investments | 203.64 | 224.4 | 189.65 | 369.2 | 554.33 | 243.55 |
Cash Growth | 7.71% | 18.32% | -48.63% | -33.40% | 127.60% | -46.68% |
Accounts Receivable | 29.68 | 47.95 | 67.79 | 53.58 | 40.32 | 52.04 |
Other Receivables | 9.79 | 3.09 | 12.84 | 8.69 | 42.96 | 5.16 |
Receivables | 39.48 | 51.04 | 80.62 | 62.27 | 83.28 | 57.2 |
Inventory | 73.03 | 76.72 | 76.66 | 84.32 | 59.1 | 60.82 |
Other Current Assets | 14.16 | 16.03 | 19.74 | 36.87 | 31.09 | 192.37 |
Total Current Assets | 330.3 | 368.18 | 366.67 | 552.66 | 727.8 | 553.95 |
Property, Plant & Equipment | 778.6 | 801.42 | 841.87 | 795.34 | 651.26 | 474.12 |
Long-Term Investments | 317.35 | 323.17 | 327.64 | 232.14 | 67.86 | - |
Goodwill | 139.49 | 139.67 | 332.09 | 365.43 | 326.68 | 336.16 |
Other Intangible Assets | 141.35 | 143.79 | 150.41 | 154.62 | 160.14 | 165.72 |
Long-Term Deferred Tax Assets | - | 0.46 | 0.78 | 0.74 | 0.82 | 0.07 |
Long-Term Deferred Charges | 92.7 | 87.89 | 67.73 | 30.45 | 4.74 | 1.87 |
Other Long-Term Assets | 9.46 | 7.67 | 19.07 | 38.91 | 17.18 | 53.47 |
Total Assets | 1,809 | 1,872 | 2,106 | 2,170 | 1,956 | 1,585 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 70.86 | 120.19 | 137.04 | 123.11 | 80.85 | 25.93 |
Accrued Expenses | 12.37 | 57.34 | 68.81 | 53.06 | 53.9 | 69.86 |
Short-Term Debt | 139.02 | 149.61 | 105.29 | 85.98 | - | - |
Current Portion of Long-Term Debt | 71.38 | 22.82 | 4.1 | 10.41 | - | - |
Current Portion of Leases | - | 5.46 | 8.05 | 8.54 | 5.93 | - |
Current Income Taxes Payable | 3.54 | 0.03 | 1.31 | 4.52 | - | 3.8 |
Current Unearned Revenue | 14.88 | 21.26 | 19.71 | 26.39 | 49.75 | 34.49 |
Other Current Liabilities | 40.82 | 14.59 | 33.16 | 55.68 | 15.39 | 61.2 |
Total Current Liabilities | 352.88 | 391.3 | 377.47 | 367.7 | 205.82 | 195.27 |
Long-Term Debt | 62.83 | 108.57 | 111.55 | 37.07 | - | - |
Long-Term Leases | 6.34 | 14.5 | 25.34 | 33.68 | 33.76 | 37.61 |
Long-Term Unearned Revenue | 8.46 | 2.81 | 2.22 | 2.47 | - | - |
Long-Term Deferred Tax Liabilities | 8 | 3.87 | - | - | 1.42 | - |
Total Liabilities | 438.51 | 521.04 | 516.59 | 440.92 | 240.99 | 232.89 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 374.13 | 374.13 | 375.93 | 379.16 | 372.51 | 322.59 |
Additional Paid-In Capital | 898.21 | 898.21 | 903.73 | 912.8 | 888.99 | 630.63 |
Retained Earnings | 105.15 | 85.62 | 324.3 | 455.64 | 444 | 399.25 |
Treasury Stock | -6.77 | -6.77 | -14.33 | -27.92 | - | - |
Total Common Equity | 1,371 | 1,351 | 1,590 | 1,720 | 1,705 | 1,352 |
Minority Interest | 0.03 | 0.03 | 0.04 | 9.7 | 10 | - |
Shareholders' Equity | 1,371 | 1,351 | 1,590 | 1,729 | 1,715 | 1,352 |
Total Liabilities & Equity | 1,809 | 1,872 | 2,106 | 2,170 | 1,956 | 1,585 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 279.57 | 300.95 | 254.34 | 175.69 | 39.69 | 37.61 |
Net Cash (Debt) | -75.93 | -76.55 | -64.69 | 193.51 | 514.64 | 205.94 |
Net Cash Growth | - | - | - | -62.40% | 149.90% | -54.92% |
Net Cash Per Share | -0.20 | -0.21 | -0.17 | 0.53 | 1.61 | 0.64 |
Filing Date Shares Outstanding | 407.1 | 374.13 | 375.93 | 379.16 | 372.51 | 322.59 |
Total Common Shares Outstanding | 407.1 | 374.13 | 375.93 | 379.16 | 372.51 | 322.59 |
Working Capital | -22.58 | -23.11 | -10.81 | 184.96 | 521.99 | 358.67 |
Book Value Per Share | 3.37 | 3.61 | 4.23 | 4.54 | 4.58 | 4.19 |
Tangible Book Value | 1,090 | 1,068 | 1,107 | 1,200 | 1,219 | 850.59 |
Tangible Book Value Per Share | 2.68 | 2.85 | 2.95 | 3.16 | 3.27 | 2.64 |
Buildings | - | 374.7 | 373.99 | 372.77 | 372.77 | 371.38 |
Machinery | - | 583.28 | 571.12 | 528.14 | 391.32 | 364.87 |
Construction In Progress | - | 351.06 | 335.22 | 273.35 | 207.59 | 8.13 |